Ridogrel Versus Aspirin Patency Trial - RAPT

Description:

RAPT was a randomized trial of ridogrel, a combined thromboxane A2 synthase inhibitor and thromboxane A2/prostaglandin endoperoxide receptor antagonist, versus aspirin in patients with acute myocardial infarction (MI) being treated with streptokinase.